HDL Therapy for the Treatment of Cardiovascular Diseases

By  

Current Vascular Pharmacology, Vol. 7, Iss. 4, 2009-01 ,pp. : 550-556

Bentham Science Publishers

Access to resources Recommend Favorite

Antithrombotic and Hypofibrinogenetic Therapy in Acute Ischemic Stroke: What Is the Next Step?

By  

Cerebrovascular Diseases, Vol. 17, Iss. 1, 2003-12 ,pp. : 138-143

Karger

Access to resources Recommend Favorite

Safety and tolerability of simvastatin plus niacin in patients with coronary artery disease and low high-density lipoprotein cholesterol (The HDL Atherosclerosis Treatment Study)

By Zhao X.-Q.   Morse J.S.   Dowdy A.A.   Heise N.   DeAngelis D.   Frohlich J.   Chait A.   Albers J.J.   Brown B.G.  

The American Journal of Cardiology, Vol. 93, Iss. 3, 2004-02 ,pp. : 307-312

Elsevier

Access to resources Recommend Favorite

HDL inflammation and atherosclerosis: current and future perspectives

By Sampietro Tiziana   Bigazzi Federico   Puntoni Mariarita   Bionda Alberto  

Future Cardiology, Vol. 2, Iss. 1, 2006-01 ,pp. : 37-48

Future Medicine

Access to resources Recommend Favorite

HDL Elevators and Mimetics - Emerging Therapies for Atherosclerosis

By  

Cardiovascular & Hematological Agents in Medicinal Chemistry (Formerly Current Medicinal Chemistry - Cardiovascular & Hematological Agents), Vol. 5, Iss. 1, 2007-01 ,pp. : 55-66

Bentham Science Publishers

Access to resources Recommend Favorite